Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

DLY vs BMEZ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BMEZ Wins Head-to-Head Institutional Verdict (1–0 across 6 Pillars · 3–1 Matrix Metrics)

BMEZ Overall Winner 6-Pillar Tally: DLY 0 – 1 BMEZ (5 Tie) Matrix Metrics: DLY 1 – 3 BMEZ

As of Nov 16, 2026, BlackRock Health Sciences Term Trust (BMEZ) is the stronger overall head-to-head candidate over DoubleLine Yield Opportunities Fund (DLY) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). DLY carries a Unified Composite Score of 42.3/100 (HOLD) at $13.10 (N/M Forward P/E, N/A operating margin), whereas BMEZ carries 46.8/100 (HOLD) at $16.91 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: DLY is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.0); meanwhile BMEZ trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DLY vs BMEZ
DLY NYSE
DoubleLine Yield Opportunities Fund
Institutional Equity
$13.10
+0.61% 1D
Market Cap $736.6M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.40β · 14% Vol
Unified Composite Score
42.3 / 100 HOLD
Tech 47.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.3%) with fading momentum, RSI 46
RSI-14: 46.0 · SMA20: $13.20 · SMA50: $13.27
BMEZ NYSE Head-to-Head Winner
BlackRock Health Sciences Term Trust
Institutional Equity
$16.91
-1.57% 1D
Market Cap $913.8M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.63β · 22% Vol
Unified Composite Score
46.8 / 100 HOLD
Tech 46.0 Fund 46.0 Flow 50.0 Mom 41.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.1 · SMA20: $17.30 · SMA50: $16.84

6-Pillar Scorecard Institutional Category Breakdown (DLY 0 – 1 BMEZ)

Columns: Metric · DLY · BMEZ
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale BMEZ
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap $736.6M $913.8M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DLY (1) vs BMEZ (3)
Institutional Metric DLY BMEZ Criterion Row Edge
Market Capitalization
Scale
$736.6M $913.8M Larger Scale BMEZ
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
8% ($13–$15) 75% ($14–$18) Stronger Trend BMEZ
Beta / 30D Volatility
Risk Regime
0.40β · 14% Vol 0.63β · 22% Vol Lower Realized Risk DLY
Unified Institutional Score
Composite Signal
42.3 / 100 (HOLD) 46.8 / 100 (HOLD) Higher Composite BMEZ
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BMEZ +3.96 pp
DLY: -0.15% · BMEZ: +3.81%
3M Horizon BMEZ +11.1 pp
DLY: -7.29% · BMEZ: +3.81%
6M Horizon BMEZ +28.49 pp
DLY: -5.69% · BMEZ: +22.8%
1Y Horizon BMEZ +23.69 pp
DLY: -10.58% · BMEZ: +13.11%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DLY vs BMEZ. Trailing 12-month operating profitability (DLY N/A vs BMEZ N/A) and valuation multiples (DLY N/M vs BMEZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

DLY ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
BMEZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DLY UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DLY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BMEZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BMEZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DLY Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $736.6M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
BMEZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $913.8M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ DLY vs BMEZ Key Questions & Quantitative Answers

As of Nov 16, 2026, BlackRock Health Sciences Term Trust (BMEZ) is the stronger overall head-to-head candidate over DoubleLine Yield Opportunities Fund (DLY) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). DLY carries a Unified Composite Score of 42.3/100 (HOLD) at $13.10 (N/M Forward P/E, N/A operating margin), whereas BMEZ carries 46.8/100 (HOLD) at $16.91 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: DLY is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.0); meanwhile BMEZ trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BMEZ leads the Growth & Scale pillar: DLY posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with BMEZ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, DLY generates N/A in USD-normalized revenue versus N/A for BMEZ. In operating R&D and SG&A reinvestment, DLY deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BMEZ.

DLY and BMEZ trade at balanced relative valuation multiples. DLY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BMEZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DLY (N/A ROE) versus BMEZ (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, DLY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.40β · 14% Vol realized risk). By comparison, BMEZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.63β · 22% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.